ONCOLOGY_HEADER

MEDICAMEN BIOTECH LIMITED IS NOW NSE LISTED

ONCOLOGY_HEADER

Company is poised to launch novel oncology products in the FY 2021- 2022 in Indian region and South East Asian markets.

ONCOLOGY_HEADER

Haridwar Unit 1 for formulations is WHO GMP approved